Dr Bill Nelson speaks with Dr Victor Velculescu, the new Associate Director of Precision Medicine for the Kimmel Cancer Center, about using genomic research to develop treatment options for patients.
Posts by Clinton Petty:
Dr Ben Levy talks to Dr Matt Ladra, Director of Pediatric Radiation Oncology for Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, about treating childhood cancer with radiation and the new proton therapy center that will be coming online at Sibley in the Fall of 2019.
Johns Hopkins Kimmel Cancer Center Director Dr. Bill Nelson talks to Dr. Elana Fertig about how she is using genomic research, mathematical modeling, chaos theory and her past experience in weather prediction to develop treatments for cancer in our latest podcast.
Dr Bill Nelson and biologist Andrew Ewald discuss the new ways that scientists are confronting the cancer on the cellular level and using physics to study how cancer cells spread to new areas. Dr Ewald was recently featured in a piece from The Hub at JHU. You can read that here.
Dr. Ben Levy, the Director of Medical Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC, begins his podcast series talking with Rasheda Persinger, and Nurse Practitioner at Sibley. They discuss the key role of Advanced Practice Providers in delivering care to cancer patients and helping them navigate the […]
Kimmel Cancer Center Director Dr Bill Nelson talks to Dr Ted DeWeese, the Center’s Director of the Department of Radiation Oncology and Molecular Radiation Sciences, about the advances in radiation therapy and how treatments are becoming more refined and targeted. In the Fall of 2019 at proton therapy center that will come online at Sibley […]
Dr Bill Nelson, the Director of the Kimmel Cancer Center at Johns Hopkins, begins a new podcast series focused on cancer treatment and research. In episode one, Dr Nelson speaks with Dr Elizabeth Jaffee, the Kimmel Cancer Center’s Deputy Director and the Associate Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, from the annual meeting […]